A new study suggests a blood test called 'VeloCD' can predict the trajectory of an illness and how well a patient might respond to treatment by measuring key markers in the blood.
Even by conservative assumptions that 5 to 10 per cent of infected individuals develop long Covid, India today may be home to 50 to 100 million infected individuals -- many silently coping with breathlessness, fatigue, palpitations, brain fog, or unexplained clotting tendencies.
Dr Sulbha Arora, clinical director and fertility specialist at Nova IVF Fertility, explains everything you need to know about egg freezing in India, including the process, the cost and the risks involved.
Reliance Clinical Research Services has commenced studies for clients in the United States, the United Kingdom and West Asia in areas including infectious diseases, vaccines and oncology to take advantage of India's competitiveness.
The pop singer revealed on Instagram that he has been diagnosed with the infectious disease.
'We have to be wary because if an uncontrolled transmission happens, random mutations may lead to something which could be virulent and then that could land us in a problem.'
The trial began at the Kaiser Permanente Washington Health Research Institute in Seattle as the first participant received the investigational vaccine.
The finding underscores the importance of hand washing or using a sanitiser to prevent the spread of COVID-19.
'This means that there is a higher likelihood of individuals who have recovered from COVID-19 to be reinfected with the Omicron variant'
According to these experts, a monkeypox outbreak can effectively be tackled by strong surveillance.
The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration led by the US Health and Human Services, which aims at accelerating the development and manufacturing of medical countermeasures for COVID-19 and delivering 300 million doses of an effective vaccine by January 2021.
Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.
Scientists said the patients who were obese, had hypertension or poorly managed diabetes had a higher risk of dying compared to those who did not have these conditions.
The team led by researchers at the University of Maryland in the United States found that people infected with SARS-CoV-2 exhale infectious virus in their breath, and those infected with the Alpha variant put 43 to 100 times more virus into the air than people infected with the original strains of the virus.
There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.
PLSL's lead molecule under development for cancer treatment has completed two Phase-I studies.
rediffGURU Chandrakant Lahariya tells you how to lower your blood sugar levels and manage your diabetes.
Manoj K Jain is an infectious disease physician, a writer, and a national leader in health-care quality improvement. Memphis-based Jain, 45, also writes for publications including The Washington Post.
If the vaccine is safe and shows a promising immune response in humans, then larger trials would be planned for later in the year.
The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.
'Kerala is probably the only state, where (with regard to) the clinical management and the overall protocols, we have an infectious disease team heading the whole containment plan.'
The White House described the development as "quite good news".
The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.
The new outbreak may be the greatest wave of illnesses ever recorded since China's stringent zero-Covid programme was abandoned last winter, which resulted in up to 85 per cent of the population being sick at the time.
rediffGURU Mayank Chandel offers advice to students interested in a careers in science or engineering after class 10 and 12.
Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication.
The government has ordered monoclonal antibody from Indian Council of Medical Research to treat the child. It is the only available anti-viral treatment for Nipah virus infection, though it has not been clinically proven yet.
Centre has sent an advisory to states on HFMD (Hand Foot and Mouth Disease), commonly known as Tomato Flu, stating that it's a self-limiting illness targeting mostly young children aged 1-10 years and immune-compromised adults and no specific drug exists to treat it.
Monkeypox is a rare zoonotic disease that is caused by infection with monkeypox virus. Monkeypox virus belongs to the family Poxviridae, which also includes the viruses causing smallpox and cowpox disease
Union Health Secretary Rajesh Bhushan said upcoming festivals and mass congregations in different parts of the country may potentially facilitate transmission of infectious diseases, including COVID-19.
'However, the importance of children in transmitting the virus remains uncertain,' the scientists cautioned in the study. 'Coronaviruses are a large family of viruses that can cause infection and disease in animals, capable of rapid mutation and recombination, leading to novel viruses that can spread from animals to humans,' they said.
The quaint little village of Perumapalayam near Erode is excited about Indian American, Dr Celine Gounder making it to the United States President-elect Joe Biden's COVID-19 advisory board since she has her roots in it and for her continuing support to its residents.
Vaccine inequity remains an issue in India, where less than 2 per cent of the population has received a Covid booster
The efficacy of the vaccine, developed by the Gamalaya Centre, was demonstrated on the basis of a first interim analysis obtained 21 days after the first injection.
This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.
The study, which was conducted on more than 100 healthcare workers at three centres in India including Sir Ganga Ram Hospital, found that the B.1.617.2 Delta variant not only dominates vaccine-breakthrough infections with higher respiratory viral loads compared to non-Delta infections (Ct value of 16.5 versus 19) but also generates greater transmission among the fully vaccinated HCWs.
These drugs will be entering in their global Phase -3 clinical trials early next year.
Jayalalithaa was admitted to Apollo Hospital on September 22.
Kang said that "at the moment, India is doing fine" but maintained that surveillance should be ensured to "detect signal of any changes in the behaviour of the virus".
Antibody levels are higher when people receive the COVID-19 vaccine in the afternoon as compared to the morning, according to an observational study.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances